Immune-mediated lung is considered the result of an exacerbated innate injury immune response, although a role for adaptive lymphocytes is emerging. αβ T cells specific for S. aureus enterotoxin A orchestrate a Tγδ17 response during lung injury. However, the mechanism driving IL-17 production is unclear. Here, we show a role for IL-2 triggering IL-17 production by lung granular γδ T cells as IL-17 synthesis and neutrophil recruitment was reduced by IL-2 blocking mAbs in vitro and in vivo. Mass cytometry analysis revealed that lung γδ T cells responded directly to IL-2 as evident from STAT5 phosphorylation and RoRγt expression. IL-2 receptor blocking mAbs and JAK inhibition impaired STAT5 phosphorylation and IL-17 release. Moreover, inhalation of S. aureus enterotoxin A induced IL-2 secretion and caspase-1-dependent IL-1β activation to drive IL-17 production. This T-cell-mediated inflammasome-dependent IL-17 response is maximum when lung Tγδ17 cells were sequentially stimulated first with IL-2 then IL-1β. Interestingly, when IL-2 is given therapeutically to cancer patients it carries a known risk of lung injury that is largely indistinguishable from that seen in sepsis. Hence, this novel mechanism reveals therapeutic targets treating both acute lung injury and high-dose IL-2 toxicity in cancer.
INTRODUCTION
Recent evidence shows that T cells can regulate innate immunity, 1 such as memory T cells facilitating innate immune cell recruitment amplifying local immunity. [2] [3] [4] Although acute lung injury and acute respiratory distress syndrome (ALI/ARDS) have been considered to be driven by the innate immune response, evidence for the participation of T cells is emerging. Consistent with a role for T cells in ALI/ARDS, several reports observed a significant increase in CD4 and CD8 T cells expressing activation and proliferation markers in bronchoalveolar lavage (BAL) of patients during the early phase of ARDS. 5, 6 Moroever, specific αβ T cells drive lung injury in mice after inhalation of Staphylococcus aureus enterotoxin. [7] [8] [9] Importantly, interleukin (IL)-2 is regarded as a biomarker for ARDS severity. 10, 11 When IL-2 is given therapeutically to cancer patients it carries a known risk of lung injury that is largely indistinguishable from that seen in sepsis. 12, 13 Similarly, IL-2 administration to rats induces pulmonary inflammation. 14, 15 Altogether these observations suggest a role for T cells and IL-2 in ALI/ARDS.
Staphylococcus aureus infection contributes to higher morbidity/ mortality during influenza coinfection 16 and healthcare-associated pneumonia, 17 and is a major cause of ARDS associated with pneumonia. 18, 19 Host defense against S. aureus lung infection has been shown to be mediated by γδ T cells. 20 This might be related to the role of γδ T cells as a primary source of IL-17, which facilitates bacterial clearance, but also contributes to lung injury during S. aureus lung infection. A major virulence mechanism of S. aureus is the release of enterotoxins that are well known to induce lethal toxic shock in people. 21, 22 These enterotoxins are regarded as superantigens since, without being processed, they bind MHC II and link specific Vβ regions of the TCR on T cells to drive massive production of cytokines and proliferation. [23] [24] [25] We recently demonstrated that after S. aureus enterotoxin A inhalation, lung γδ T cells produced IL-17, even though they are not known to bind S. aureus enterotoxin A, but interestingly they required αβ T cells for their activation. 26 Here, we describe how αβ T cells induce pulmonary γδ T-cell activation. The data demonstrate that enterotoxins induce rapid release of IL-2, which activates pulmonary γδ T cells to synthesize pro-inflammatory IL-17. Ex vivo culture of pulmonary γδ T cells with IL-2 -induced IL-17 production and CyTOF analysis demonstrated STAT5 activation and RoRγt expression within a small subpopulation of granular Tγδ17 cells. This contrasts from the antagonizing role IL-2 plays in Th17 differentiation, 27 and shows that IL-17 release from Tγδ17 cells is JAK/STAT dependent. Mechanistically, we found that IL-2 worked in concert with IL-1β to drive IL-17 production by both bulk and sorted lung γδ T cells. Thus, our data suggests that high levels of IL-2 activates Tγδ17 cells, producing IL-17 driven pulmonary injury. Moreover, IL-2 cancer immunotherapy could be void of adverse IL-17-based events with the use of IL-17 blockade. Mice  C57BL/6 and caspase 1/11 -/-(stock #16621) mice were purchased from the Jackson Laboratory (Bar Harbor, ME Tissue processing and cell isolation BAL was collected by lavage of mouse lung with sterile PBS. BAL was centrifuged at 1000 rpm at 4°C to separate cells from BALF and 0.2 µm filtered as described earlier. 28 Lungs were homogenized post-BAL lavage using MagNA Lyser Green Beads (Roche, Basel, Switzerland) at 6000 rpm. Protein was quantified using BCA assay (Thermo Fisher Scientific, Waltham, MA). Lymph node cells obtained from axillary and inguinal lymph nodes were crushed through 100 µm nylon mesh cell strainers (BD Biosciences), washed with BSS and counted using ZI particle counter (Beckman Coulter). Lung cells were obtained as described before. 26 Briefly, lung tissue was perfused with PBSheparin (0.055 g/L), cut into small pieces, and incubated with 1.3 mM EDTA/PBS at 37°C for 20 min, washed, followed by digestion with collagenase solution containing collagenase from Clostridium histolyticum IV (150 U/ml), 1 mM MgCl 2 , 1 mM CaCl 2 , in BSS, at 37°C for 20 min. Subsequently digested lung tissues were crushed through 100 µm nylon mesh cell strainers (BD Biosciences) and partitioned between a 44 and 67% Percoll gradient to obtain cells at the interface. For CyTOF experiments, lung cells were processed with a few modifications to facilitate the flow of cells through the CyTOF. Briefly, lung tissue was perfused with PBS/EDTA, washed and digested at 37°C for 30 min with collagenase solution containing DNAse I (60 Unit/ml). Residual lung tissue was crushed through 40 µm nylon mesh cell strainers (BD Biosciences) and cells were purified using Lympholyte M (Cedarlane Labs, Burlington, NC). γδ T cell were enriched by negative magnetic isolation with Dynabeads biotin binder (InVitrogen) and biotinylated antibodies to CD8 (2.43), CD4 (GK1.5), MHC class II (I/A-E), PECAM1/CD31 (390) and NK1.1 (PK136). CD3+ GL3+ cells were sorted from the enriched population on a FACS Aria II (BD).
MATERIALS AND METHODS
Flow cytometry and CyTOF Flow cytometry was performed as described before. 8 Intercalator-Ir. The pooled sample was spiked with normalization beads and analyzed by a mass cytometer (Helios, Fluidigm). The data were debarcoded using the Fluidigm Debarcoder v1.04. A single-cell gate and a live cell gate were obtained from each sample. The samples were further sub-gated to include the same number of cells per sample and merged to create the viSNE maps (MATLAB; MathWorks, Natick, MA) using only the non-signaling markers. Histograms comparing the expression of signaling and activation markers were generated using MATLAB, 29 similar to our previous approach. 30 Immunization and cytokine neutralization Mice were anesthetized with isoflurane (Vedco Inc., Saint Joseph, MO) and given 1 or 0.25 μg of S. aureus enterotoxin A (as indicated in figure legend) diluted in 50 μl of BSS, or BSS alone by intranasal (i.n.) route as previously described. 26 IL-2 neutralization was carried out by intraperitoneal injection of 1 mg of anti-IL-2 antibody clone S4B6 and 1 mg of anti-IL-2 antibody clone JES6-1A12 30 min prior to S. aureus enterotoxin A immunization. Rat IgG was used as a control in a separate group. In vitro antibody neutralization was carried out using antibodies specific for IL-1β (clone B122), IL-2 (clones S4B6-1 and JES6-1A12), IL-23 (clone AF1619), CD25 (clone PC-61.5.3), CD122 (clone TM-β1).
In vitro and ex vivo cell culture Cells were cultured for 20 h, or the indicated time, at 37°C and 5% CO 2 in 200 μl complete tumor medium (CTM), consisting of modified Eagle's medium with 5% fetal bovine serum, amino acids, salts and antibiotics. Cells were seeded in 96-well roundbottom plates and stimulated with media alone, S. aureus enterotoxin A (0.5 µg/ml), rmIL1β (10 ng/ml), rhIL-2 (100U/ml), or PMA (50 ng/ml; Calbiochem, Darmstadt, Germany) plus ionomycin (1 µg/ml; Invitrogen). For analysis of secreted cytokines, tissue culture plates were centrifuged and tissue culture medium analyzed by ELISA. For intracellular cytokine staining analysis, BFA was added to the culture and cells were stimulated as indicated in figure legend. Cells were stained and analyzed by flow cytometry.
Statistical analysis A two-tailed Student's unpaired test was used for data analysis, with values of p < 0.05 (*) used as significant threshold; p < 0.01 is indicated as (**) and p < 0.001 as (***). All statistical analyses were performed using Prism-GraphPad (La Jolla, CA).
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RESULTS
γδ T cells respond to S. aureus enterotoxin A by producing IL-17 through an IL-2-dependent cytokine circuit Lung γδ T cells release IL-17 within hours of S. aureus enterotoxin A inhalation, but a strict requirement for the presence of TCRαβ T cells during this process is noted. 26 To uncover the role each tissue-specific T-cell population plays, S. aureus enterotoxin Adriven IL-17 synthesis was explored in an in vitro co-culture assay involving lung cells (as source of lung γδ T cells), and lymph node (LN) cells (as source of αβ T cells). After an overnight culture γδ T cells producing IL-17A (herein referred to as IL-17) were detected, but only those with increased Side Scatter (SSC) scale (termed hereafter as lung granular γδ T cells) were capable of synthesizing IL-17 (Fig. 1a, b) . No other population of IL-17 + producer was detected ( Supplementary Fig. 1a ) and the TCR usage of these granular IL-17 + γδ T cells was mainly TCR Vγ2
with a slightly greater percentage TCR Vγ2
+ as compared to IL-17 Fig. 2 ). Finally, IL-17 detection by intracellular cytokine staining required the absence of brefeldin A (BFA) in the first 6 h (Fig. 1a) , as continual BFA presence in the culture resulted in no IL-17 production ( Supplementary Fig. 1b) , suggesting a secreted factor such as a cytokine after S. aureus enterotoxin A stimulation was required for IL-17 synthesis by the granular γδ T cells. Cytokines secreted into the culture were measured and, consistent with the intracellular cytokine staining in Fig. 1a , IL-17 was detected at high levels when LN and lung cells were cocultured (Fig. 1c, top panel) . Perhaps surprisingly, the Th17 expansion cytokine IL-23 31 was not detected above background (Fig. 1c, middle) , but IL-2 was significantly produced by LN cells cultured alone or with lung cells (Fig. 1c, bottom) . We postulated that IL-2 might induce IL-17 production by lung granular γδ T cells.
This was tested by incubating LN+ lung cells with S. aureus enterotoxin A and anti-IL-2 mAb to inhibit IL-2 function. The results demonstrated a significant reduction in IL-17 during IL-2 neutralization (Fig. 1d) . Additionally, lung cells stimulated in vitro with IL-2 produced IL-17 by granular γδ T cells, but only modestly when stimulated with other cytokines such as IL-3, IL-4, IL-7, IL-15, IL-17, IFNγ, and TGFβ ( Supplementary Fig. 3 ). Ultimately, this contrasts with the prevailing idea that IL-2 suppresses Th17 cell differentiation. 27 One possibility to explain this apparent contradiction, is that the granular γδ T cells, characterized by the expression of the key Th17 transcription factor RoRγt, may be fully differentiated to IL-17 expression under conducive conditions in the lung.
Defining lung granular γδ T cells as differentiated Tγδ17 cells Granular γδ T cells in the lung constitute a rare population, Mass cytometry (CyTOF) was utilized to characterize this population. CyTOF analysis revealed γδ T cells as positive for CD3 and TCRγδ, and negative for many other markers such as CD4, CD8, MHC II, Gr-1, CD11b, CD11c, CD19, NK1.1, Siglec-F (Fig. 2) . As shown in Fig. 2a , after viSNE mapping, granular γδ T cells segregated into discrete subpopulations that either express high or very low levels of RoRγt. Most importantly the RoRγt hi cells (herein referred to as Tγδ17 cells) were concurrently positive for pSTAT5 4 h after S. aureus enterotoxin A inhalation (Fig. 2a, b) . Other non-Tγδ17 cells express high RoRγt but were negative for pSTAT5, pSTAT1, and pSTAT3 ( Supplementary Fig. 4a ). pSTAT1 and pSTAT3 also were elevated in Tγδ17 after S. aureus enterotoxin A inhalation and pSTAT1 was slightly elevated in RoRγt lo cells as well (Fig. 2b) . Thus, the lung Tγδ17 cells responded to S. aureus enterotoxin A with specific increases in pSTAT5 suggesting that they responded locally in vivo to the cytokine milleu. Supplementary Fig. 4b ). Moreover, when blocking mAbs specific for either the high-affinity (CD25) or low-affinity (CD122) IL-2 receptors were added to an in vitro culture prior to IL-2 stimulation, a modest decrease in pSTAT5 expression was observed, but robust inhibition occurred upon neutralization of both IL-2 receptors (Fig. 3a, b) . Similarly, the non-granular lung γδ T cells also expressed pSTAT5 after IL-2 exposure suggesting that their lack of IL-17 production (Fig. 1) was a consequence of very low RoRγt. To further test the pathway responsible for IL-17 synthesis, IL-2R signaling was blocked using Ruxolitinib, a JAK inhibitor known to interfere with phosphorylation of STAT5. 32 IL-17 production by lung cells stimulated with IL-2 was significantly inhibited with Ruxolitinib (Fig. 3c) , but importantly TNF synthesis by the same cells stimulated with PMA+ ionomycin was not affected (Fig. 3d) . Thus, IL-2 promotes IL-17 release by lung Tγδ17 cells.
Lung Tγδ17 cells rely on IL-2 and inflammasomes activated by S. aureus enterotoxin A Since the data uncovered the presence of pSTAT5 + lung Tγδ17 cells (Fig. 3) , an early event in IL-2 signaling, it was reasoned that IL-2 release occurred rapidely after S. aureus enterotoxin A inhalation. Over a 48 h time period IL-2 levels in serum, lung tissue, and BAL fluid were measured by ELISA (Fig. 4a) . IL-17 was also detected in BAL fluid 24 h post S. aureus enterotoxin A inhalation ( Supplementary Fig. 5 ). Importantly, a fast and robust release of IL-2 was evident at 4 h in all tissues examined followed by a rapid decline (Fig. 4a) . While these data demonstrate the presence of circulating IL-2 and its localized presence in lung, they do not show that IL-2 actually impacts the lung Tγδ17 cells in vivo after S. aureus enterotoxin A inhalation.
To test this idea a strategy was used to neutralize IL-2 in vivo, which as noted by others can be difficult to achieve. 33 A previously documented method using anti-IL-2 mAbs with specificity to IL-2 and to the IL-2 receptor was employed. 34 Immunization with 1 µg of enterotoxin released high local and systemic IL-2 levels (Fig. 4a) that were difficult to neutralize. However, a low dose of enterotoxin (0.25 µg) still induced substantial IL-17 expression by the lung Tγδ17 cells, which was significantly inhibited by IL-2 blockade (Fig. 4b,c) . Neutrophil accumulation in the lung was also inhibited by IL-2 blockade (Fig. 4d) . Supported by previous results demonstrating that lung Tγδ17 cells depend on TCRαβ T cells to produce IL-17, 26 and that gut effector memory Th17 cells are induced by systemic enterotoxin administration, 35 it was postulated that IL-2 plays a role in IL-17 synthesis. However, IL-2 does not likely function alone in this capacity.
Several cytokines direct Th17 differentiation including IL-1β, IL-6, TGFβ, and IL-23. Of these we found no evidence for IL-23′s involvement (Fig. 1c) even after IL-2 stimulation ( Supplementary  Fig. 6a ), which suggested that IL-1β might be the best candidate since it is necessary for optimal gut γδ T-cell IL-17 responses. 36 This was tested in mice intranasally (i.n.) treated for 6 h with vehicle, S. aureus enterotoxin A, or bacterial LPS (to serve as an innate immune driver of IL-17). After cell isolation and 5 h culture the vehicle alone resulted in background IL-17 synthesis but the immunized mice yielded lung Tγδ17 cells with robust IL-17 production (Fig. 5a ). In the S. aureus enterotoxin A-treated mice, ex vivo IL-1β neutralization substantially inhibited IL-17 production, but interestingly IL-1β neutralization had no effect in the LPS-treated mice (Fig. 5a, b) . These data suggest that S. aureus enterotoxin A inhalation promotes IL-2 release that, along with IL-1β, drives lung Tγδ17 cell IL-17 production. To test this mechanism, we evaluated if lung γδ T cells were readily capable to respond to IL-2 and IL-1β. Lung cells from naive mice were stimulated with IL-2 in the presence of IL-1β neutralization (Fig. 5c ) or with CD25 blockade (Fig. 5d) . IL-2 with blockade of IL-1β or CD25 resulted in significantly reduced IL-17 production (Fig. 5c, d) , and IL-23 blockade had no effect (Supplementary Fig. 6a ). Moreover, IL-2 blockade did not affect IL-23-induced IL-17 ( Supplementary Fig. 6b ).
To define this mechanism further, and test if IL-1β is matured by inflammasome activated caspase 1, caspase 1/11 -/-mice were treated with vehicle or S. aureus enterotoxin A for 6 h and then lung cells were cultured ex vivo followed by intracellular IL-17 measurement. The data show markedly less production of IL-17 in caspase 1/11 -/-cells (Fig. 6a, b) , which suggests that caspases 1 and/or 11 play a role in promoting the maturation of IL-1β that, in combination with IL-2, induces IL-17 synthesis. Secondly, offering IL-2 to wild-type or caspase 11 -/-cells induced IL-17 release, but caspase 1/11 -/-cells produced significantly less IL-17 (Fig. 6c) . Specifically, IL-17 production in wild-type and caspase 11 -/-cells was inhibited when IL-1β was neutralized, and adding IL-1β with IL-2 rescued IL-17 release in caspase 1/11 -/-cells, whereas IL-1β alone did not. Finally, the sequence of cytokine addition for optimal IL-17 release was determined using caspase 1/11 -/-lung cells to control for the IL-1β level in culture. Neither IL-2 nor IL-1β alone promoted IL-17 production (Fig. 6d, first three columns) , and IL-17 production was greatest with IL-2 stimulation before IL-1β (Fig. 6d, last two columns) . Similarly, in sorted wild-type lung γδ T cells, neither IL-2 nor IL-1β alone promoted IL-17 production, but they synergized to produce IL-17 when given together (Fig. 6e) .
DISCUSSION
A growing body of research shows that T cells function as antigenspecifc sentinels that alert the local innate cells to respond to infection and tissue damage. 2, 3, 37 We have previously shown that S. aureus enterotoxin A-specific αβ T cells regulate IL-17 synthesis by lung γδ T cells, affecting neutrophil recruitment, but the molecular mechanism was unclear. 26 Here, we show that IL-2 release in synergy with caspase-1 dependent IL-1β production is required for IL-17 production by lung Tγδ17 cells. These data demonstrate that IL-2 from αβ T cells can compromise pulmonary homeostasis, dependent on an IL-1β checkpoint.
Our study provides evidence that granular Tγδ17 cells are the only source of IL-17 in response to pulmonary S. aureus enterotoxin A challenge ( Fig. 1a and Supplementary Fig. 1a ). This cell population differed from classical γδ T cells by its higher granularity and expression of granzyme B (Fig. 1a and data not shown). However, TCR specificity did not seem a key factor as IL-17-producing granular lung Tγδ17 cells expressed similar TCRγ chain than non-producing cells ( Supplementary Fig. 2 ). In this model, IL-17 production was inhibited by IL-2 blockade in vitro (Fig. 1d) , and in vivo (Fig. 4d, c) and IL-2 itself induced IL-17 production by granular lung Tγδ17 cells (Fig. 3c, Supplementary Figs. 3 and 6 and Supplementary Fig. 6 ). From a mechanistic perspective, we observed that shortly after S. aureus enterotoxin A inhalation RoRγt-expressing γδ T cells phosphorylarted STAT5 and STAT3 (Fig. 2) . A similar CyTOF approach demonstrated that RoRγt + Tγδ17 cells from steady-state lung are capable of responding directly to IL-2 by rapidly phosphorylating STAT5 (Supplementary Fig. 4b ). The detection of pSTAT5 and pSTAT3 in lung Tγδ17 cells suggests that both transcription factors contribute to IL-17 production as observed in other systems. Moreover, our data suggest that Tγδ17 cells from naive lung used the IL-2 signaling pathway to phosphorylate STAT5 and express IL-17 (Fig. 3) . From a translational perspective, the inhibition of IL-17 synthesis mediated by Ruxolitinib (a FDA approved JAK1 and JAK2 inhibitor 39, 40 ) offers new avenues for ALI/ARDS intervention. The low but constitutive level of pSTAT5 detected in lung Tγδ17 cells in the absence of exogenous stimulation suggests that this subpopulation of cells has the potential to rapidly respond to cytokines in steady-state lung and initiate local inflammation. These data demonstrated a key role for IL-2 in facilitating IL-17 production, contrasting from the established inhibitory role of IL-2 on Th17 polarization. 27, 38 Hence, IL-2 promotes rapid IL-17 synthesis by lung Tγδ17 cells to initiate innate immunity at the site of insult or damage and neutrophil recruitment (Fig. 4d) , while inhibiting Th17 differentiation and systemic IL-17-mediated inflammation. Mapping STAT5 binding in lung Tγδ17 by ChIPseq and deleting the relevant sites by CRISP/Cas9 technology would provide new insight in the epigenetic regulation of IL-17.
Our model revealed that T cells stimulated IL-1β activation which is required for granular lung Tγδ17 cell IL-17 production in synergy with IL-2 (Figs. 5 and 6 ). We demonstrated the requirement for IL-1β ex vivo using neutralizing anti-IL-1β (Fig. 5a,b) , and in vivo using caspase 1/11 -/-mice challenged intranasally with S. aureus enterotoxin A (Fig. 6a, b ). This observation is surprising but consistent with the inflammasomedependent production of IL-17 by γδ T cells previously observed at the site of S. aureus infection. 41 It is also possible that some IL-1β was produced by other mechanisms independent of the inflammasome but not tested in this study. 42 Additional studies will be required to find the cellular source of IL-1β, but it is perhaps not by coincidence that γδ T cells throughout the lung of naive mice have been found predominantly in physical contact with MHC II + and F4/80 + myeloid cells that could function to release IL-1β. 43 Moreover, MHC II is expressed by alveolar macrophages and dendritic cells, 44 and S. aureus enterotoxin A inhalation induces rapid migration of monocytes to lung and upregulation of MHC II. 7, 26 In contrast with other studies showing that CD11c
+ cells produced a large quantity of IL-23 in LPSinduced lung injury, 45 and CD103 + dendritic cells produce IL-23 in response to invasive pulmonary aspergillosis, 46 our study shows IL-17 production that appears independent of IL-23 ( Fig. 1c and Supplementary Fig. 6a, b) . The apparent lack of IL-23 and the absence of direct γδ TCR activation are consistent with a novel mechanism where IL-1β and IL-2 bind lung Tγδ17 cells and induce IL-17 production. Directly related to this alternate mechanism is the appearance of maximal IL-17 levels only when lung Tγδ17 cells are first stimulated with IL-2 then with IL-1β (Fig. 6d) . This was confirmed by using sorted lung γδ T cells stimulated with IL-2 then with IL-1β (Fig. 6e) . This is strikingly similar to adjuvant function where out-of-sequence adjuvant signals corrupt cellular responses. 47, 48 Thus, inflammation is tightly regulated not only by the specific cytokine or costimulatory mediators but also by their sequential triggering of receptors.
Our data indicated that local inflammation could be promoted by a subpopulation of lung Tγδ17 cells in response to a high level of systemic IL-2 and local IL-1β to produce and release IL-17. Lung γδ T cells are known to produce IL-17, cause inflammation and initiate lung injury, 20, 49 but our study precisely defines a subpopulation of lung Tγδ17 cells that bridges the systemic adaptive immune system with local innate signals. The outcome of this reponse is lung inflammation, which could explain why cancer treatment with high IL-2 doses induces side effects remarkably similar to pulmonary injury in sepsis. 12, 13 Hence, targeting lung Tγδ17 could be an innovative approach to both limit lung inflammation during ALI/ARDS and decrease the toxicity of IL-2-based cancer immunotherapy.
Altogether, our study sheds new light on a novel link between αβ T cells and lung Tγδ17 cells, provides a new mechanism contributing to the understanding of the toxicity of high IL-2 levels, and underscores the importance of targeting cytokines in the development of new therapeutic interventions against lung injury.
